En Carta Diagnostics
FranceEntry
2025
Hold
1yr
Status
Active
Who owns En Carta Diagnostics?
En Carta Diagnostics is a French MedTech company, currently owned by Malakoff Humanis Innov' since 2026 and 50 Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
50 Partners50 Partners Capital Health · 2022 · VC
2 ownership periods · full history below
Key facts
HQFrance
SectorMedTech
Ownership history
2 ownership periods
Active
50 PartnersActive
2025 · present(1yr) · 50 Partners Capital Health · 2022 · VC
Malakoff Humanis Innov'Active
2026 · present(<1yr) · MH Innov' · 2018 · VC
More from 50 Partners Capital Health
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns En Carta Diagnostics?
En Carta Diagnostics is currently owned by Malakoff Humanis Innov' and 50 Partners, through 50 Partners Capital Health, since 2026.
When did Malakoff Humanis Innov' and 1 other acquire En Carta Diagnostics?
Malakoff Humanis Innov' and 1 other acquired En Carta Diagnostics in 2026.
Who has owned En Carta Diagnostics over time?
En Carta Diagnostics has been through 2 private-equity ownership periods: 50 Partners · via 50 Partners Capital Health · since 2025; Malakoff Humanis Innov' · via MH Innov' · since 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue